Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Jinshuibao for CKD Due to Glomerulonephritis
NCT04349683Phase 4Unknown
- Sponsor
- Jemincare
- Start
- Apr 2020
- Primary completion
- Aug 2021
- Modality
- HM (Herbal Medicine), FDP (Fungal-derived product)
01
Overview
A Phase 4 trial of fermented cordyceps sinensis mycelia powder in chronic kidney disease (CKD), sponsored by Jemincare. Status: unknown.
02
Drugs
fermented cordyceps sinensis mycelia powder
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04349683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349683.